Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma [1] (multiple letters)

American Journal of Ophthalmology

Volumn 136, Issue 2, 2003, Pages 392-393

  Fellenbaum, Paul S ^a   Noecker, Robert S ^a   Dirks, Monte S ^a   Choplin, Neil T ^a   Bernstein, Paula ^a   Batoosingh, Amy L ^a   Whitcup, Scott M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; FLUOROURACIL; FLUPROSTENOL; LATANOPROST; MITOMYCIN C; PROSTAGLANDIN F2 ALPHA; TIMOLOL;

CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; FIBROBLAST; FIBROSIS; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; LETTER; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT FAILURE; WOUND HEALING;

EID: 0041347612     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00247-2     Document Type: Letter

References (8)

1. Summary basis of approval for LUMIGAN, on the Food and Drug Administration website. Available at: http://www.fda.gov/cder/foi/nda/2001/21275Lumigan.htm. Accessed on 14 February 2003
2. E. Guglielminetti S. Barabino M. Monaco S. Mantero M. Rolando HLA-DR expression in conjunctival cells after latanoprost J Ocul Pharmacol Ther 18 2002 1 9
3. Noecker R, Herrygers, L, Anwaruddin R. Comparison of conjunctival inflammation and corneal damage caused by commonly used glaucoma medications. Abstract presented at the American Glaucoma Society meeting in 2002. American Glaucoma Society website. Available at: http://www.glaucomaweb.org/abs2002/poster19.php
4. B. Cvenkel A. Ihan Ocular surface changes induced by topical antiglaucoma monotherapy Ophthalmologica 216 2002 175 179
5. D.F. Woodward R.A. Lawrence Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells Biochem Pharmacol 47 1994 1567 1574
6. D.F. Woodward A.H.-P. Kraus J. Chen The pharmacology of bimatoprost (Lumigan) Surv Opthalmol 45 Suppl 4 2001 S337 S345
7. Woodward DF, Kraus AH-P, Chen J, et al. Pharmacological characterization of a novel antiglaucoma agent, bimatoprost (AGN 192024). J Pharmacol Exp Ther 2003. Forthcoming
8. E.J. Higginbotham J.S. Schuman I. Goldberg One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension Arch Ophthalmol 120 2002 1286 1293